First institutional analysis between ultra vs moderate hypofractionated regimens in prostate cancer

To evaluate efficacy and acute and chronic gastrointestinal (GI) and genitourinary (GU) toxicities between…" />

We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.